Bonus Biogroup (BONS) - Total Liabilities

Latest as of June 2025: ILA19.00 Million ILA ≈ $50.95K USD

Based on the latest financial reports, Bonus Biogroup (BONS) has total liabilities worth ILA19.00 Million ILA (≈ $50.95K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Bonus Biogroup to assess how effectively this company generates cash.

Bonus Biogroup - Total Liabilities Trend (2008–2024)

This chart illustrates how Bonus Biogroup's total liabilities have evolved over time, based on quarterly financial data. Check Bonus Biogroup (BONS) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Bonus Biogroup Competitors by Total Liabilities

The table below lists competitors of Bonus Biogroup ranked by their total liabilities.

Company	Country	Total Liabilities
Astra Graphia Tbk JK:ASGR	Indonesia	Rp1.03 Trillion
Red Star Macalline Group Corporation Ltd F:3S5	Germany	€68.62 Billion
Bhiraj Office Leasehold Real Estate Investment Trust BK:BOFFICE	Thailand	฿2.56 Billion
Gevelot PA:ALGEV	France	€54.03 Million
Shanghai Jinjiang International Travel Co Ltd SHG:900929	China	$532.93 Million
Bancroft Fund Limited NYSE MKT:BCV	USA	$226.12K
Korvest Ltd AU:KOV	Australia	AU$30.87 Million

Liability Composition Analysis (2008–2024)

This chart breaks down Bonus Biogroup's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bonus Biogroup (BONS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-11.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bonus Biogroup's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bonus Biogroup (2008–2024)

The table below shows the annual total liabilities of Bonus Biogroup from 2008 to 2024.

Year	Total Liabilities	Change
2024-12-31	ILA16.45 Million ≈ $44.10K	+5.55%
2023-12-31	ILA15.58 Million ≈ $41.78K	-14.47%
2022-12-31	ILA18.22 Million ≈ $48.85K	-8.40%
2021-12-31	ILA19.89 Million ≈ $53.33K	-4.15%
2020-12-31	ILA20.75 Million ≈ $55.64K	+0.20%
2019-12-31	ILA20.71 Million ≈ $55.53K	+55.31%
2018-12-31	ILA13.34 Million ≈ $35.75K	+11.49%
2017-12-31	ILA11.96 Million ≈ $32.07K	+16.59%
2016-12-31	ILA10.26 Million ≈ $27.50K	+43.58%
2015-12-31	ILA7.14 Million ≈ $19.16K	+82.32%
2014-12-31	ILA3.92 Million ≈ $10.51K	+128.91%
2013-12-31	ILA1.71 Million ≈ $4.59K	+23.97%
2012-12-31	ILA1.38 Million ≈ $3.70K	+54.99%
2011-12-31	ILA891.00K ≈ $2.39K	-97.99%
2010-12-31	ILA44.26 Million ≈ $118.67K	-24.68%
2009-12-31	ILA58.77 Million ≈ $157.56K	+50.91%
2008-12-31	ILA38.94 Million ≈ $104.40K	--

About Bonus Biogroup

TA:BONS Israel Biotechnology

Market Cap

$129.94 Million

ILA48.47 Billion ILA

Market Cap Rank

#18204 Global

#234 in Israel

Share Price

ILA41.50

Change (1 day)

+0.48%

52-Week Range

ILA19.50 - ILA58.50

All Time High

ILA171.00